Eli Lilly (LLY) Staring at Tremendous Opportunity in Alzheimer Market: RBC Capital Markets
Eli Lilly and Company (NYSE:LLY) is one of the 13 best blue-chip stocks to buy, according to analysts.
Eli Lilly & Co (LLY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 5,438,446 | $4,491,667,635 | +4% | 1.94% |
| 2. | 1,935,700 | $1,598,713,987 | -10% | 0.3% | |
| 3. | GQG Partners Rajiv Jain | 1,829,453 | $1,510,963,352 | -60% | 2.41% |
| 4. | 1,649,500 | $1,362,338,545 | -12% | 0.26% | |
| 5. | Tiger Global Management LLC Chase Coleman And Feroz Dewan | 1,334,960 | $1,102,556,814 | +2% | 4.15% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $304.19 | 656 | $199,548.64 | 62,857 | 2022-08-12 | Filing | |
| $246.78 | 202 | $49,849.56 | 15,436 | 2022-03-01 | Filing | |
| $182.99 | 546 | $99,912.54 | 61,195 | 2021-04-30 | Filing | |
| $182.74 | 820 | $149,846.80 | 60,649 | 2021-04-30 | Filing | |
| $108.84 | 1,000 | $108,840.00 | 22,043 | 2019-10-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $716.41 | 1,000 | $716,410.00 | 4,840 | 2025-05-27 | Filing | |
| $749.24 | 1,250 | $936,550.00 | 27,510 | 2025-05-14 | Filing | |
| $818.24 | 1,000 | $818,240.00 | 5,840 | 2025-03-13 | Filing | |
| $934.89 | 812 | $759,129.87 | 96,016,978 | 2025-03-03 | Filing | |
| $933.74 | 3,997 | $3,732,138.80 | 96,017,790 | 2025-03-03 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 19,071 | $14,866,833 | 3.07% | |
| 2. | 12,502 | $9,745,906 | 1.38% | |
| 3. | 10,793 | $8,413,467 | 0.28% | |
| 4. | 10,113 | $7,883,734 | 0.7% | |
| 5. | 7,147 | $5,571,301 | 0.71% |
News See All
13 Best Blue Chip Stocks to Buy According to Analysts
The US equity market has recorded a stunning recovery after President Donald Trump's tariff policies sent markets on a tailspin in April.
15 Set-It-and-Forget-It Stocks to Buy According to Analysts
As expectations for trade agreements and potential rate cuts reduced investor anxiety, the S&P 500 and Nasdaq reached record closing highs on June 30, concluding their strongest quarter in over a year...
FDA Approves Updated Label For Eli Lilly and Company (LLY)'s Amyvid To Support Alzheimer’s Diagnosis
Eli Lilly and Company (NYSE:LLY) is among the Goldman Sachs Stock Portfolio: 10 Large-Cap Stocks To Buy.
Goldman Sachs Stock Portfolio: 10 Large-Cap Stocks To Buy
The S&P 500 rose by 0.52% on Friday to close at a record high of 6,173.07, marking returns of 3.44% for the week, as traders looked past the termination of trade talks between the United States and Canada...
Truist Reiterates Eli Lilly (LLY) Buy Rating on Orforglipron Diabetes Drug Data
Eli Lilly and Company (NYSE:LLY) is one of the 12 stocks that will make you rich in 10 years. On June 23, Truist Securities reiterated its “Buy” rating on Eli Lilly stock.
12 Stocks That Will Make You Rich in 10 Years
One of the most read (and recommended) books on investing is Benjamin Graham’s The Intelligent Investor. Among many others, long-term investing is a foundational theme in the book.
13 Best Long Term Growth Stocks to Invest in Right Now
She said that the equity market is looking beyond tariffs instead of focusing on them.
Eli Lilly & Co. (LLY) is Recovering from the Period of Volatility
Macquarie Asset Management, an investment management company, released its “Macquarie Large Cap Growth Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Eli Lilly Mounjaro Sees Strong Reception in India, Rising Demand Amid Obesity, Diabetes Rates
Eli Lilly and Company (NYSE:LLY) is one of the best Fortune 500 stocks to buy according to billionaires.
Billionaire Hedge Funds
